, Tracking Stock Market Picks
Enter Symbol:
Boston Scientific Corporation (BSX) [hlAlert]

Mkt Perform
down 49.14 %

Boston Scientific Corporation (BSX) downgraded to Mkt Perform by Leerink Swann

Posted on: Tuesday,  Sep 18, 2012  8:25 AM ET by Leerink Swann

Leerink Swann rated Mkt Perform Boston Scientific Corporation (NYSE: BSX) on 09/18/2012. Previously Leerink Swann rated Outperform Boston Scientific Corporation (NYSE:
BSX) on 08/18/2009., when the stock price was $11.09. Since then, Boston Scientific Corporation has lost 49.14% as of 09/18/2012's recent price of $5.64.
If you would have followed the previous Leerink Swann 's recommendation on BSX, you would have lost 49.14% of your investment in 1127 days.

Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of minimally invasive medical devices. The company's products are used in a broad range of interventional medical specialties, including cardiology, electrophysiology, gastroenterology, neuro-endovascular therapy, pulmonary medicine, radiology, urology and vascular surgery.

Leerink Swann Equity Research provides unique perspectives and agenda-setting healthcare recommendations for investors. Supported by industry-based intelligence and thorough market examination, our proprietary research enables our clients to make well-informed healthcare investment decisions. Our investment perspectives are driven by proprietary insights from MEDACorp. MEDACorp's more than 25,000 network professionals work with new and/or development-stage pharmaceuticals, medical devices and biotherapeutics on a daily basis. MEDACorp's extensive knowledge of products and research enables Leerink Swann to provide growth-focused clients an expertise earned through experience.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/18/2012 8:25 AM Hold
as of 12/31/2012
1 Week   
1 Month   
3 Months   
1 YTD up  5.61 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/18/2009 8:25 AM Buy
6/23/2008 8:25 AM Hold

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy